Alveus Therapeutics, Inc.

Pharmaceutical company · Philadelphia, Pennsylvania, United States

Alveus Therapeutics, Inc. is a pharmaceutical company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $57 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Alveus Therapeutics at a glance

Typepharmaceutical company

HeadquartersPhiladelphia, Pennsylvania, United States

Earliest incorporation on record2023

SEC CIK2075856

What does Alveus Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $56.9 million sold (2026).

Frequently asked questions about Alveus Therapeutics

Where is Alveus Therapeutics headquartered?

Alveus Therapeutics, Inc. is headquartered in Philadelphia, Pennsylvania, United States.

What does Alveus Therapeutics do?

Alveus Therapeutics, Inc. is a pharmaceutical company.

When was Alveus Therapeutics founded?

The earliest incorporation on record for Alveus Therapeutics, Inc. is in 2023, according to public company registers.

Similar companies

Context Therapeutics Inc.Philadelphia, Pennsylvania, United States
Lannett Co IncPhiladelphia, Pennsylvania, United States
Carisma Therapeutics Inc.Philadelphia, Pennsylvania, United States
Avid Radiopharmaceuticals, Inc.Philadelphia, Pennsylvania, United States
EpiVario Inc.Philadelphia, Pennsylvania, United States
Verismo Therapeutics, Inc.Philadelphia, Pennsylvania, United States
Aro Biotherapeutics CoPhiladelphia, Pennsylvania, United States
Mebias Discovery, Inc.Philadelphia, Pennsylvania, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences